October 2, 2019 – Dinas Kesehatan Provinsi DKI Jakarta (DKI Jakarta Provincial Public Health Office) initiated a regional meeting for puskesmas (public health center), hospitals, clinics, and Dinas Kesehatan Kabupaten (public health office on district level). This official event was conducted to implement the Instruksi Presiden No. 6 Tahun 2016 (The 2016 Presidential Injunction No. 6) about the escalation on the development of the pharmaceutical and medical devices industry. Accompanied by Sumber Mitra Agungjaya, PT and Innovasi Diagnostika, PT representing local distributors in the Jakarta area, Proline’s local products were introduced effectively toward end-users from healthcare laboratories around the province of Jakarta.
Up to 50 decision-makers from the public health center and 95 stakeholders from the public and private hospitals with BPJS Kesehatan (Social Security Administrator for Health Services) were invited. Twelve leading manufacturers of domestic medical devices including Proline were introduced, and the event was hosted successfully for two days. Moreover, Proline also got a chance to present brief information about the company profile for 10 minutes in front of the invitees. The comprehensive introduction of Proline’s product features was positively received by the audiences. Most of the attentive audiences are keenly interested in the availability of Proline’s long expiry date reagents at the e-catalog site and also the stability of reagent’s performance.